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Available online 20 October 2016Background: Obesity andmetabolic syndrome lead to the development of metabolic heart disease (MHD) that is
characterized by left ventricular hypertrophy (LVH), diastolic dysfunction, and increasedmitochondrial ROS. Ca-
loric restriction (CR) is a nutritional intervention that protects against obesity, diabetes, and cardiovascular dis-
ease. Healthy adipose tissue is cardioprotective via releasing adipokines such as adiponectin. We tested the
hypothesis that CR can ameliorate MHD and it is associated with improved adipose tissue function as reﬂected
by increased circulating levels of high molecular weight (HMW) adiponectin and AMP-activated protein kinase
(AMPK) in db/dbmice.
Methods:Genetically obese db/db and lean db/+malemicewere fed either ad libitum or subjected to 30% CR for 5
weeks. At the end of the study period, echocardiographywas carried out to assess diastolic function. Blood, heart,
and epididymal fat pads were harvested for mitochondrial study, ELISA, and Western blot analyses.
Results: CR reversed the development of LVH, prevented diastolic dysfunction, and decreased cardiac mitochon-
drial H2O2 in db/db (vs. ad lib) mice. These beneﬁcial effects on the heart were associatedwith increased circulat-
ing level of HMW adiponectin. Furthermore, CR increased AMPK and eNOS activation in white adipose tissue of
db/dbmice, but not in the heart.
Conclusions: These ﬁndings indicate that even short-term CR protects the heart fromMHD.Whether the beneﬁcial
effects of CR on the heart could be related to the improved adipose tissue function warrants future investigation.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Adipose tissue1. Background
Obesity and metabolic syndrome are associated with metabolic
heart disease (MHD) [2]. The key features of MHD are left ventricular
hypertrophy (LVH), diastolic dysfunction, and compromised mitochon-
drial function with impaired energetics and increased ROS production
[6,13]. Over time,MHDcan lead to clinical heart failurewith a preserved
ejection fraction (HFpEF) which is associated with serious conse-
quences for morbidity and mortality. Caloric restriction (CR) is an
effective dietary intervention that protects against obesity-related
comorbidities such as diabetes and cardiovascular disease [7]. It is not
known whether CR can protect the development of obesity-related
MHD. However, in rodents, CR ameliorates diastolic dysfunction in-
duced by abdominal aortic constriction, ischemic/reperfusion injury,
and aging [7,22]. Accordingly, our ﬁrst goal was to determine whether
short-term (5 weeks) CR can ameliorate the development of MHD in
genetically-obese db/dbmice.
The mechanism by which CR exerts beneﬁcial effects on the heart is
not precisely known. Several possibilities have been suggestedland Ltd. This is an open access articlincluding reversal of insulin resistance, activation of myocardial AMPK
and/or SIRT1 signaling, and increased circulating levels of the
cardioprotecive adipokine adiponectin [8,23]. Recently, we observed
that roux-en-y gastric bypass, an extreme form of CR, markedly in-
creased adipose tissue AMPK activity and circulating levels of HMW
adiponectin in obese patients [28]. AMPK is a pivotal nutrient sensor
with the ability to regulate whole-body metabolism [10]; whereas adi-
pose tissue exerts paracrine and endocrine actions on the heart by re-
leasing a variety of adipokines. For example, circulating levels of
adiponectin are decreased in obese humans and rodents, and a deﬁcien-
cy in adiponectin may contribute to the pathophysiology of several car-
diovascular diseases including heart failure [19]. Therefore, our second
goalwas to explore adipose tissue AMPK signaling and adiponectin pro-
duction in db/dbmice with CR intervention.
2. Methods
2.1. Animals and CR
10-week old male db/db and littermate lean db/+mice were pur-
chased from Jackson Laboratory (Bar Harbor, ME). Upon arrival, mice
had ad libitum access to water and chow diet and were on a 12: 12 he under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and food intake was recorded daily for 3–4 days. Next, mice were ran-
domized into the following treatment groups for 5 weeks: control (ad
libitum; D12450B, Research Diets, New Brunswick, NJ), or 30% CR
(D03020702B, Research Diets). The CR diet is a 30% reduction in carbo-
hydrate intake, and designed to limit total energy consumption while
insuring adequate nutrition. The amount of food consumed by the db/
db and the db/+ ad libitum groups was recorded daily, and 70% of that
was given to the respective CR groups. Body weights were monitored
weekly. At the whole-body level, CR prevented weight gain in db/db
and caused weight loss in db/+ mice. At the end of the study, hearts
were harvested for isolation of mitochondria and the remaining was
snap-frozen in liquid nitrogen and stored at−80 °C for further use. Ep-
ididymal fat pads were excised, snap-frozen, and stored at−80 °C. All
animal protocols were approved by the Boston University Institutional
Animal Care and Use Committee.
2.2. Measurements in blood
Mice were fasted overnight and blood samples were collected from
the chest cavity when the hearts were excised. Blood glucose wasmea-
sured using an ACCU-CHEK Aviva glucometer (Roche, Indianapolis, IN).
Commercial kits were used to measure plasma levels of insulin (ALPCO,
Salem, NH), HMW & total adiponectin (ALPCO), resistin (R&D Systems,
Minneapolis, MN), and visfatin (BioVision).
2.3. Western blot analyses
Total proteins were isolated from the heart that had been homoge-
nized in RIPA buffer (Boston BioProducts, Ashland, MA) supplemented
with protease (Roche) and phosphatase (Sigma-Aldrich, St. Louis, MO)
inhibitors. Protein lysates from epididymal fat were prepared in lysis
buffer (Cell Signaling, Beverly, MA). Protein concentrations wereFig. 1. Effects of 5-week CR on bodyweight, fasting blood glucose and insulin in db/db and db/+
Data are means ± S.E.M. (n = 6/group).determined using the bicinchoninic acid assay (ThermoScientiﬁc, Rock-
ford, IL). Tenmicrogramsof proteinwere separated by gel electrophore-
sis, transferred to a PVDFmembrane (Millipore, Billerica, MA), and then
incubated with primary antibodies as described previously [29].
Phospho (Thr172) and total AMPK, phospho (Ser1177) and total eNOS
were purchased from Cell Signaling Technology. Antibody for GAPDH
was from Santa Cruz Biotechnology (Santa Cruz, CA). Proteins were vi-
sualized by enhanced chemiluminescence (Thermo Scientiﬁc), and
quantiﬁed with Scion Image Software (NIH).2.4. Mitochondrial ROS production
Mitochondria from the hearts were isolated as previously described
[16]. Brieﬂy, heartswereminced in cold relaxation buffer, homogenized
in buffer containing 5 mM HEPES, 1 mM EDTA, 0.25 M sucrose with
pH 7.4. The resulting lysates were centrifuged at 500 ×g for 10 min,
4 °C. The supernatant was centrifuged at 9000 ×g for 15 min, 4 °C. The
pellet (mitochondria) was re-suspended in 100 μL buffer containing
125mMKCl, 10mMHEPES, 5 mMMgCl2, 2mMK2HPO4. Mitochondrial
H2O2 productionwasmeasured using Amplex Ultra Red (Life Technolo-
gies, Grand Island, NY) as previously described [25].2.5. Two-dimensional and M-mode echocardiography and Doppler
echocardiography
LV dimensions and systolic function were measured in non-
anesthetizedmice using anAcuson Sequoia C-256 echocardiographma-
chine equipped with a 15 MHz linear transducer (model 15 L8), as we
have described previously [20]. LV diastolic function was assessed by
transmittal and tissue Doppler echocardiography in anesthetized mice
as we have previously reported [21].mice. *, p b 0.05, **, p b 0.01, ***, p b 0.0001 vs. db/db Con; $, p b 0.05, $$, p b 0.01 vs. db/+CR.
Fig. 3.Mitochondrial H2O2 productionwith a complex I substrate (A+C) and a complex II substrate (B+D)weremeasured in db/db and db/+mice. The amounts of H2O2 produced in ad
lib (Con) groups were set to 1 for both genotypes. *, p b 0.05 vs. db/db Con. Data are means ± S.E.M. (n = 6/group).
Fig. 2.Measurements of LVwall thickness (A), parameters related to diastolic (B) and systolic function (C-E) in db/db and db/+mice with CR. *, p b 0.05, **, p b 0.01 vs. db/db Con. Data are
means ± S.E.M. (n = 6/group).
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Data are expressed as means ± SE. GraphPad Prism software (La
Jolla, CA) was used for all analyses. The comparison was performed
using Student's t-test, one-way, or two-way ANOVA as appropriate.
Minimal level of signiﬁcance was set at p b 0.05.
3. Results
3.1. Effects of CR on body weight and circulating parameters
5 week, 30% CR prevented weight gain in db/db and caused weight
loss in db/+ mice (Fig. 1A). Compared to the db/+ group, the db/db
mice had higher fasting plasma glucose, which increased further with
CR (Fig. 1B). Similarly, the fasting insulin level was higher in db/db vs.
db/+ (Fig. 1C).
3.2. CR prevents LVH and diastolic dysfunction in db/db mice
Left ventricle (LV) wall thickness was increased in db/db (vs. db/+)
mice, andwas reversed by 5-weekCR (Fig. 2A). Likewise, diastolic relax-
ation, as reﬂected bymyocardial peak early diastolic velocity (Em), was
decreased in db/db (vs. db/+) mice and corrected by CR (Fig. 2B). LV
end-diastolic dimension (EDD), systolic dimension (ESD), and fractional
shortening (LVFS) were similar in db/db and db/+ ad libmice, and were
not affected by CR (Fig. 2C–E).
3.3. Mitochondrial ROS production
Complex I and II substrate-driven mitochondria H2O2 production
wasmeasured in isolated hearts. In db/dbmice, CR (vs. ad lib) decreasedFig. 4. Effects of CR on the circulating levels of adipokines. *, p bthe rate of H2O2 generation by both complex I and II substrates
(Fig. 3A,B). In contrast, CR had no effect on mitochondrial H2O2 produc-
tion in db/+mice (Fig. 3C,D).
3.4. Effect of CR on adipokine production
In epididymal fat, a visceral depot in rodents, the mRNA levels of
adiponectin, resistin, visfatin, and omentin were not signiﬁcantly differ-
ent in db/db vs. db/+mice on ad lib diet, nor were they affected by CR
(data not shown). However, the plasma levels of total and HMW
adiponectin were decreased in db/db (vs. db/+)mice (Fig. 4A,B). CR in-
creased HMW, but not total adiponectin production (Fig. 4A,B). Plasma
levels of resistin and visfatin were not different in db/db vs. db/+mice,
and were not affected by CR (Fig. 4C,D).
3.5. CR activates AMPK in white adipose tissue but not in the heart in db/db
mice
AMPK phosphorylation at residue Thr172wasmeasured as an indica-
tor of its activity [11]. In epididymal fat, AMPK phosphorylation was de-
creased in db/db vs. db/+mice, and was fully restored by CR (Fig. 5A,B).
Likewise, phosphorylation of an AMPK downstream target eNOS
(Ser1177) was decreased in db/db (vs. db/+) on ad lib diet, and was re-
stored by CR (Fig. 5C). In contrast, cardiac AMPK phosphorylation was
only slightly lower in db/db vs. db/+ on ad lib diet, and was not affected
by CR (Fig. 5D,E).
4. Discussion
Themain ﬁnding of this study is that in genetically obese db/dbmice,
CR for 5 weeks ameliorates the key features of MHD including LVH,0.05 vs. db/db Con. Data are means ± S.E.M. (n = 6/group).
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knowledge, this is the ﬁrst study to demonstrate the beneﬁcial effects
of short-term CR on obesity-related MHD in a mouse model. We also
found that CR led to increased production of HMW adiponectin, which
is associated with AMPK activation in white adipose tissue, but not in
the heart.4.1. CR prevents the development of MHD
The db/dbmouse has been shown to develop LVH and both systolic
and diastolic dysfunction [4]. In this study, we found LVH and diastolic
dysfunction in the db/dbmice on ad libitum diet, whereas systolic func-
tion as reﬂected by ejection fraction, was normal. Differences in meth-
odologies [1] and/or mice strains [27] could explain the discrepancy
between our ﬁndings (normal systolic function) vs. others (systolic dys-
function). In support of our data, systolic functionwas preserved in diet-
induced obese mice despite the presence of diastolic dysfunction [21,
25]. Two limitations should be noted. First, the evaluation of LV diastolic
function by tissue Doppler does not allow us to determine the relative
effects of CR on relaxation vs. a decrease in stiffness. Likewise, we
were unable to conﬁrm the echocardiographic assessment of LVH
with a direct measurement of mass due to the need to snap freeze the
tissue for optimal biochemical analysis.
Another important characteristic of MHD is mitochondrial dysfunc-
tion with impaired energetics and excess ROS [25,26]. Increaseddb/db Con db/db CR db/+ Con db/+ C
B C
A
db/db Con db/db CR db/+ Con db/+ CR
D
Fig. 5. Effects of CR on AMPK phosphorylation/activation in heart and epididymal fat. Relative p
p b 0.05, **, p b 0.01 vs. db/db Con. Data are means ± S.E.M. (n = 6/group).mitochondrial H2O2 production has been observed in obese db/db
mice aswell as mice with diet-induced obesity [5,25], possibly as a con-
sequence of increased fatty acid oxidation leading to electron leakage
for the electron transport chain [5,14]. CR has been shown to decrease
cardiac mitochondrial H2O2 generation in obese rats [18] and in lean
aging mice [24]. Our study extends these ﬁndings by demonstrating
that CR also diminished cardiac mitochondrial H2O2 in db/dbmice.4.2. HMW adiponectin
Adiponectin levels are known to decrease with obesity [15]. There-
fore, it was not surprising that plasma levels of adiponectin were
lower in db/db (vs. db/+) mice. While CR had no effect on total
adiponectin level in db/db mice, it increased the level of HMW
adiponectin by 3 folds. Several isoforms of adiponectin are present in
the plasma where the HMW form is considered most bioactive [15].
Since adiponectin is cardioprotective, our data suggest that the beneﬁ-
cial effects of CR are mediated, in part, by increased HMW adiponectin.
The mechanism responsible for the selective increase in HMW vs. total
adiponectin is not clear. In a study with morbidly obese humans, we
found that roux-en-y gastric bypass (an extreme form of CR) increased
circulating HMW adiponectin 3 months post-operatively, although
total adiponectinwas notmeasured [28]. In leanmice, 5 weeks of CR in-
creased all three isoforms of adiponectin [23]. Given that adiponectin is
themost abundant adipokine secreted by white adipose tissue [17], ourp-AMPKThr172
t-AMPK
R
GAPDH
p-eNOSSer1177
t-eNOS
p-AMPKThr172
t-AMPK
GAPDH
E
hospho-protein levels were normalized against total AMPK and total eNOS, respectively. *,
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health in db/db mice. In contrast to adiponectin, several other
adipokines that are known to modulate cardiovascular function were
unaffected by CR.
4.3. Role of AMPK
AMPK is a pivotal nutrient sensor with the ability to regulate whole-
body metabolism [9] and it can be activated by adiponectin. Although
cardiac AMPK has been shown to play a role in CR-mediated
cardioprotection in severalmodels [23], our data indicate that AMPK ac-
tivity in the heart was only slightly decreased in db/db (vs. db/+) mice,
and was not altered by CR. In obese humans, we demonstrated that ad-
ipose tissue AMPK activity is decreased in insulin resistant (vs. insulin
sensitive) group [29]; moreover, we found increased adipose tissue
AMPK activity associated with higher circulating levels of HMW
adiponectin following roux-en-y gastric bypass [28]. In the present
study, adipose tissue AMPK activity was markedly decreased in db/db
(vs. db/+)mice, andwas accompanied by a decrease in eNOSphosphor-
ylation, a downstream target of AMPK. Conversely, CR increased both
AMPK and eNOS phosphorylation/activation to levels comparable to
non-obese db/+ mice. Whether adipose tissue AMPK can mediate a
crosstalk with the heart warrants further investigation, as our condi-
tioned media study shows that knocking down AMPK in adipocytes
has an impact on cardiomyocyte function (Xu et al., unpublished).
4.4. Other effects of CR
Increased ROS production contributes to mitochondrial dysfunction.
In the hearts of micewith diet-induced obesity, mitochondrial ROS pro-
duction was elevated, causing oxidative post-translational modiﬁca-
tions of mitochondrial proteins and leading to impaired mitochondrial
oxidative respiration and ATP production [3,26]. Interestingly, overex-
pression of catalase targeted to the mitochondria prevented the
obesity-induced LVH, diastolic dysfunction, and it also decreased mito-
chondrial ROS level [26]. Our ﬁnding here that CR decreases cardiacmi-
tochondrial ROS generation in db/dbmice indicates that CR is associated
with improved mitochondrial function of the heart. It further raises the
possibility that the cardiac beneﬁts of CR are due, at least in part, to de-
creased mitochondrial ROS production. CR-mediated decrease in mito-
chondrial ROS could be a direct consequence of decreased cardiac
fatty acid oxidation.
While CR prevented weight gain in db/dbmice, whole-body insulin
resistance persisted. It is likely that a longer duration of CR is required
to reverse insulin resistance in db/dbmice [12]. Furthermore, we cannot
exclude the possibility that there was tissue-speciﬁc reversal of the in-
sulin resistance.
To summarize, we show for the ﬁrst time that in genetically-obese
mice, short-term CR prevents the development of MHD. These beneﬁ-
cial effects occur despite whole- body insulin resistance, and are associ-
ated with improved adipose tissue health as reﬂected by elevated
circulating HMW adiponectin and increased AMPK activation. These
ﬁndings raise an intriguing possibility that interventions that target ad-
ipose tissue may be of value in the treatment of MHD.
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